|
|
Quarterly Results |
|
Divis Laboratories Ltd | Industry : Pharmaceuticals - Indian - Bulk Drugs | Chairman : Ramesh B V Nimmagadda | Home : Indian Private | Book Value: 474.522963 | BSE Code : 532488 | Market Cap: 105128.21 | NSE Code : DIVISLAB | P / E : 77.07 | |
| |
|
|
|
|
|
(Rs in Cr.) |
|
Type | 3Qtr | 2Qtr | 1Qtr | 4Qtr | Net Sales | 1808.00 | 1868.00 | 1730.00 | 1908.00 | Other Income | 94.00 | 85.00 | 80.00 | 66.00 | Total Income | 1902.00 | 1953.00 | 1810.00 | 1974.00 | Total Expenditure | 1317.00 | 1394.00 | 1239.00 | 1419.00 | Operating Profit | 585.00 | 559.00 | 571.00 | 555.00 | Interest | 0.00 | 1.00 | 0.00 | 0.00 | Gross Profit | 585.00 | 558.00 | 571.00 | 555.00 | Depreciation | 95.00 | 94.00 | 93.00 | 87.00 | Tax | 121.00 | 108.00 | 123.00 | 105.00 | Deferred Tax | 11.00 | 14.00 | 10.00 | 44.00 | Reported Profit After Tax | 358.00 | 342.00 | 345.00 | 319.00 |
|
|
|
|
|